| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-10 19:43:09 UTC |
|---|
| Updated at | 2024-09-10 19:43:09 UTC |
|---|
| NP-MRD ID | NP0334731 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Tetrahydrogestrinone |
|---|
| Description | Tetrahydrogestrinone, also known as THG, belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. In 2003, whistleblower Trevor Graham passed a spent syringe containing a small amount of the drug to the United States Anti-Doping Agency. THG, possessing a high affinity, establishes more van der Waals contacts with the receptor than with many other steroids. Tetrahydrogestrinone is an extremely weak basic (essentially neutral) compound (based on its pKa). It is a modification of gestrinone (17α-ethynyl-18-methyl-19-nor-δ9,11-testosterone) in which the ethynyl group has been hydrogenated into an ethyl group, thereby converting the steroid from a norethisterone (17α-ethynyl-19-nortestosterone) derivative with weak AR activity into a norethandrolone (17α-ethyl-19-nortestosterone) derivative with powerful AR activity. Here it changes the expression of a variety of genes, turning on several anabolic and androgenic functions. Unlike most other anabolic steroids, THG also binds with high affinity to the glucocorticoid receptor, and while this effect may cause additional weight loss, it is also likely to cause additional side effects such as immunosuppression that are not seen with most other steroids. Tetrahydrogestrinone was first documented in 2004 (PMID: 15292520). It was developed by Patrick Arnold and was used by a number of high-profile athletes such as Marion Jones and Dwain Chambers (PMID: 15934041). |
|---|
| Structure | [H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H] InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h9,11,13,18-19,23H,3-8,10,12H2,1-2H3/t18-,19+,20+,21+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-3-one | HMDB | | THG | HMDB | | 17-HYDROXY-18a-homo-19-nor-17a-pregna-4,9,11-trien-3-one | HMDB | | 17-HYDROXY-18a-homo-19-nor-17α-pregna-4,9,11-trien-3-one | HMDB | | Tetrahydrogestrinone | MeSH |
|
|---|
| Chemical Formula | C21H28O2 |
|---|
| Average Mass | 312.4458 Da |
|---|
| Monoisotopic Mass | 312.20893 Da |
|---|
| IUPAC Name | (10S,11S,14S,15S)-14,15-diethyl-14-hydroxytetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1,6,16-trien-5-one |
|---|
| Traditional Name | tetrahydrogestrinone |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)C=CC1=C3CCC(=O)C=C3CC[C@@]21[H] |
|---|
| InChI Identifier | InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h9,11,13,18-19,23H,3-8,10,12H2,1-2H3/t18-,19+,20+,21+/m1/s1 |
|---|
| InChI Key | OXHNQTSIKGHVBH-ANULTFPQSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Estrane steroids |
|---|
| Direct Parent | Estrogens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Estrogen-skeleton
- 3-oxosteroid
- Hydroxysteroid
- 17-hydroxysteroid
- Oxosteroid
- Cyclohexenone
- Cyclic alcohol
- Tertiary alcohol
- Cyclic ketone
- Ketone
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Carbonyl group
- Alcohol
- Organooxygen compound
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|